OptimizeRx Corporation (OTCMKTS:OPRX) Files An 8-K Entry into a Material Definitive Agreement

OptimizeRx Corporation (OTCMKTS:OPRX) Files An 8-K Entry into a Material Definitive Agreement
Item 5.02

Entry into a Material Definitive Agreement
Story continues below

Officer Compensation

On February 7, 2019, we executed amendments to the employment agreement with two of our executive officers, Terry Hamilton and Doug Baker. The amendments increased the annual salary payable to Messrs. Hamilton and Baker to $230,000 and $240,000, respectively, effective January 1, 2018, Salary adjustments for other executive officers were previously approved and disclosed in previous 8-K filings.

Except as described above, the terms of the respective employment agreements with our executive officers remain in full force and effect.

The foregoing description of the amendments to employment agreements with Messrs. Hamilton and Baker does not purport to be complete and is qualified in its entirety by reference to the complete text of the amendments to employment agreements filed as Exhibits 10.1 and 10.2 hereto and incorporated herein by reference.

2013 Equity Incentive Plan

Our board of directors increased the shares of common stock reserved under our 2013 Incentive Plan from 1,833,333 shares to 2,500,000 shares.

Board Committees

As a result of the resignation of Bryan Archambault, the WPP Director, on December 21, 2018 in connection with the sale of the WPP shares, we have reassigned our independent board members to the following committees for 2019.

Nominating and Corporate Governance Committee Compensation Committee Audit Committee
Chairperson: Lynn Voss Chairperson: Jim Lang Chairperson: Patrick Spangler
Member: Jim Lang Member: Gus Halas Member: Lynn Vos
Member: Gus Halas Member: Patrick Spangler Member: Gus Halas


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

The information set forth in Items 1.01 is incorporated into this Item 5.02 by reference.

SECTION 9 – Financial Statements and Exhibits

Item 5.02 Financial Statements and Exhibits.

OptimizeRx Corp Exhibit
To view the full exhibit click here

About OptimizeRx Corporation (OTCMKTS:OPRX)

OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company’s principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs.

An ad to help with our costs